Triton Market Research’s report insinuates that the cellulite treatment market in Europe is expected to advance with a compound annual growth rate of 9.51% in revenue during forecast years 2023-2030. Germany, Italy, the United Kingdom, Spain, France, Nordic Countries, and the Rest of Europe are studied in the region.
In France, about 40% of the population is diagnosed with obesity, which has elevated the demand for various treatments. Moreover, there is a high population base of geriatric population. This has increased the need for cellulite reduction treatments over recent years. Further, as per industry sources, the availability of plastic surgeons has also increased over the past few years. Hence, the rising beauty consciousness is expected to increase the demand for skin procedures, thereby driving the cellulite treatment market on a growth path.
Furthermore, technological advancements have enhanced aesthetic procedures, attracting various consumers in Italy. There is also a rise in foreign patients seeking innovative skin treatments. In this regard, radiofrequency therapy has gained significant prominence. The surge in minimally invasive procedures has fueled an influx of medical tourists. Therefore, the rise in medical tourists and beauty consciousness opens new avenues for the cellulite treatment market across Italy.
Competitive Outlook
The notable companies in the cellulite treatment market include Johnson & Johnson, Bausch Health Companies Inc, Cutera Inc, Galderma SA, and Candela Medical Corporation.
1. Europe Cellulite Treatment Market - Summary
2. Industry Outlook
2.1.Parent Market Analysis
2.2.Impact Analysis On The Cellulite Treatment Market
2.2.1.Covid-19 Impact On The Cellulite Treatment Market
2.2.2.Ukraine-russia War Impact On The Cellulite Treatment Market
2.3.Porter’s Five Forces Analysis
2.3.1.Threat Of New Entrants
2.3.2.Threat Of Substitutes
2.3.3.Bargaining Power Of Buyers
2.3.4.Bargaining Power Of Suppliers
2.3.5.Threat Of Competitive Rivalry
2.4.Market Maturity Analysis
2.5.Industry Components
2.5.1.Research And Development
2.5.2.Manufacturing Of Product
2.5.3.Distribution
2.5.4.Post-sales Monitoring
2.6.Regulatory Framework
2.7.Key Buying Impact Analysis
2.7.1.Price
2.7.2.Brand Name
2.7.3.Usability
2.8.Key Market Strategies
2.8.1.Collaborations
2.8.2.Product Launches
2.8.3.Mergers & Acquisitions
2.8.4.Business Divestitures & Expansions
2.9.Market Drivers
2.9.1.Growing Prevalence Of Obesity
2.9.2.Rapidly Growing Medical Tourism Sector
2.9.3.Rising Demand For Aesthetic Procedures
2.10.Market Challenges
2.10.1.Lack Of Knowledge Regarding Cellulite Treatment
2.10.2.High Price Of Advanced Cellulite Treatment
2.10.3.Risks Associated Post-treatment
2.11.Market Opportunities
2.11.1.Rising Beauty Consciousness
2.11.2.Increasing Trend Of Anti-cellulite Massage
2.11.3.Growing Demand For Minimally Invasive And Non-invasive Procedures
2.11.4.Rising Popularity Of Radiofrequency Therapy For Cellulite Treatment
2.11.5.Advancements In Technologies And New Product Launches
2.12.Analyst Perspective
3. Europe Cellulite Treatment Market – By Cellulite Type
3.1.Soft Cellulite
3.2.Hard Cellulite
3.3.Edematous Cellulite
4. Europe Cellulite Treatment Market – By Procedure Type
4.1.Non-invasive
4.2.Minimally Invasive
4.3.Topical
5. Europe Cellulite Treatment Market – By End-user
5.1.Hospitals
5.2.Clinics And Beauty Centers
5.3.Other End-users
6. Europe Cellulite Treatment Market – By Country Outlook